Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Epidemiology

Cancer Management

What Causes Cancer?

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Prevention: Lowering your Risk

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Glossary

Cancer Symptoms

Hot vs Cold: the differences between tumor types

What is Cancer of Unknown Primary?

The Effects of Cancer on Family Life

See more featured articles »

Cancer Pain

Overview of Cell Viability and Cytotoxicity

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Effects of Social and Economic Deprivation on Cancer Mortality

Caring for a Loved One with Cancer

Cancer Pathophysiology

TARDIS: The Improved Method of Detecting Breast Cancer

Is Cancer a Metabolic Disorder?

Pediatric Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Investigating the Molecular Mechanisms of Cancer

Cancer Prognosis

What is Tumorigenesis?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Diagnosis

Myc Mutations and Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Acidosis and Tumor Progression

The Cancer Cell Surface Proteome as a Therapeutic Target

Hypoxia Markers and Their Importance

What is the Tumor Microenvironment?

Insight into Cancer Vaccines

Cutaneous Manifestations of Internal Malignancy

What is Cancer?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Transforming Cancer Care through Genomic Testing

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Secondary Brain Cancer

The Biochemistry of Breast Cancer Screening

Using Biomarkers to Detect Cancer

Cancer Pain Management

Targeted Cancer Therapies

Cancer Research

Insights into Oncofertility

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Classification

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Living with Cancer Pain

Cancer Screening Considerations: Balancing the Benefits and Risks

What Role do Biobanks Play in Cancer Research?

Secondary Lung Cancer

CDK9 and Cancer

Cancer History

Extracellular Vesicles as Floating Cancer Biomarkers

What is Immunochemotherapy?

What is Merkel Cell Carcinoma?

British Pioneers in Cancer Biology

Why are Cancer Cell Lines Useful?

Latest Cancer News and Research

Researchers uncover how bacterial toxin damages colon lining cells to trigger cancer

Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon.

8 May 2026

Cardiometabolic diseases remain leading cause of excess American mortality

Between 1999 and 2022, the US had substantially higher death rates than other wealthy nations, largely due to cardiovascular disease, metabolic diseases (including diabetes), Alzheimer's disease and related dementias, and drug and alcohol complications.

8 May 2026

Multi-center research initiative aims to improve glioblastoma patient outcomes

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center are part of a new multi-institution research effort aimed at improving care and outcomes for patients diagnosed with glioblastoma, one of the most aggressive and difficult-to-treat cancers.

8 May 2026

Study challenges assumptions about testosterone’s role in brain cancer

Scientists have long suspected that androgens, male sex hormones like testosterone, may help tumors grow because the hormones can suppress immune responses to some cancers.

8 May 2026

A brain-based approach may improve smoking cessation treatment success

For many people who smoke, quitting is not just a matter of willpower. It is a tug-of-war in the brain – between the pull of reward and the ability to resist.

8 May 2026

Engineered regulatory T cells offer a path toward immunosuppression-free transplants

Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address chronic rejection and carries long-term side effects including infection, malignancy, and metabolic disorders.

8 May 2026

AI-powered MRI scans predict diabetes and heart disease risk

Research shows AI-enhanced MRI body composition metrics can predict diabetes and heart disease risks, offering insights for better health screening practices.

8 May 2026

UK media portrays Type 1 and Type 2 diabetes stigma differently

Media framing often differs between diabetes types, with implications for misconceptions, blame, and diabetes-related stigma.

8 May 2026

New nanoparticles disable drug resistance to achieve complete tumor elimination

Cancer cells frequently develop the ability to expel anticancer drugs before they can work -- a phenomenon called multidrug resistance (MDR) -- which is one of the leading reasons why chemotherapy fails in patients.

8 May 2026

The power of organoids in speeding up lifesaving drug development

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult stem cells, etc.) or progenitor cells in an in vitro three-dimensional culture system, which possess structural features and partial functions analogous to their corresponding in vivo organs. In 2009, the Hans Clevers laboratory developed the first intestinal organoid, marking the inception of organoid-based disease modeling.

8 May 2026

Prisoners in England face dramatically higher rates of avoidable healthcare harms

Prisoners in England are 41 to 67 times more likely to experience avoidable harms as a result of poor healthcare than the general public, suggest the findings of a case note review of medical records, published online in the journal BMJ Quality & Safety.

8 May 2026

Legumes and soy foods may help reduce hypertension risk

A higher dietary intake of soy and legumes is linked to a lower risk of high blood pressure, finds a pooled data analysis of the available evidence, published in the open access journal BMJ Nutrition Prevention & Health.

8 May 2026

Diverse leukemia stem cells may drive AML relapse after therapy

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML).

7 May 2026

Long telomeres linked to higher lymphoma risk in families

Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres - the protective caps at the ends of chromosomes - allow immune cells to remain biologically "younger" for longer than normal, predisposing affected individuals to lymphoma and other cancers.

7 May 2026

Chromosome abnormalities may help cancer cells resist treatment and spread

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, which are DNA strands wound up in bundles that control which genetic instructions are followed in each cell type.

7 May 2026